About the Authors

Hiroaki Takeuchi

htake.molv@tmd.ac.jp (HT); shojimmb@tmd.ac.jp (SY)

Affiliation Department of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan

Hideki Saito

Affiliation Department of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan

Takeshi Noda

Affiliations Division of Ultrastructural Virology, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, PRESTO, Japan Science and Technology Agency, Saitama, Japan, Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan

Tadashi Miyamoto

Affiliation Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, Shionogi & CO., LTD, Osaka, Japan

Tomokazu Yoshinaga

Affiliation Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, Shionogi & CO., LTD, Osaka, Japan

Kazutaka Terahara

Affiliation Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan

Hiroshi Ishii

Affiliation AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan

Yasuko Tsunetsugu-Yokota

Affiliations Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan, Department of Medical Technology, School of Human Sciences, Tokyo University of Technology, Tokyo, Japan

Shoji Yamaoka

htake.molv@tmd.ac.jp (HT); shojimmb@tmd.ac.jp (SY)

Affiliation Department of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan

Competing Interests

TM and TY are employed by Shionogi & Co., Ltd, and HT received funding from Shionogi & Co., Ltd. The other authors declare that no other competing interests exist.

Author Contributions

Conceptualization: HT SY. Data curation: HT SY HS. Formal analysis: HT SY. Funding acquisition: HT SY. Investigation: HT HS TN KT YTY HI TM TY SY. Methodology: HT TN KT YTY. Project administration: HT SY. Resources: HT TN KT. Supervision: HT SY. Validation: HT HS TN KT YTY TM TY HI. Visualization: HT TN KT YTY SY. Writing – original draft: HT TN KT SY. Writing – review & editing: HT SY.